Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group

Ciampi E.; Guerra-Posada C.; Treviño-Frenk I.; Cortes-Enriquez F.; Correa-Díaz E.P.; Steinberg J.; Fragoso Y.; Garcia Bonitto J.; Macias M.A.; Novarro N.; Carra A.; Vizcarra D.; Vrech C.; Carcamo C. · Multiple Sclerosis and Related Disorders (2022) · DOI: 10.1016/j.msard.2022.103649

Resumen

MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis have been recently published, and they have been fundamental for improving patient care. Implementation of these and previous MAGNIMS recommendations have not been established in many countries. Addressing the local limitations behind these difficulties is needed. A panel of 14 MS neurologists from 16 different reference centres from Chile, Argentina, Mexico, Colombia, Ecuador, Panamá, Perú and Brazil met to discuss the current situation regarding the use of MRI in MS including a) Access and availability, b) Standardized acquisition protocols and reports, and c) Multicentric research potential.